Veracyte Inc (VCYT)
20.92
+0.57
(+2.80%)
USD |
NASDAQ |
May 06, 16:00
20.92
0.00 (0.00%)
After-Hours: 20:00
Veracyte Cash from Investing (Quarterly): -2.497M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.497M |
| September 30, 2023 | -2.802M |
| June 30, 2023 | -3.669M |
| March 31, 2023 | 24.08M |
| December 31, 2022 | -26.43M |
| September 30, 2022 | 8.807M |
| June 30, 2022 | -9.307M |
| March 31, 2022 | -2.453M |
| December 31, 2021 | 0.385M |
| September 30, 2021 | -165.46M |
| June 30, 2021 | 1.473M |
| March 31, 2021 | -575.61M |
| December 31, 2020 | -0.888M |
| September 30, 2020 | -1.635M |
| June 30, 2020 | -0.649M |
| March 31, 2020 | -0.665M |
| December 31, 2019 | -41.10M |
| September 30, 2019 | -0.226M |
| June 30, 2019 | -0.658M |
| March 31, 2019 | -0.749M |
| December 31, 2018 | -0.454M |
| September 30, 2018 | -0.659M |
| Date | Value |
|---|---|
| June 30, 2018 | -0.534M |
| March 31, 2018 | -0.227M |
| December 31, 2017 | -0.30M |
| September 30, 2017 | -0.727M |
| June 30, 2017 | -0.113M |
| March 31, 2017 | -0.175M |
| December 31, 2016 | -0.448M |
| September 30, 2016 | -0.173M |
| June 30, 2016 | -0.614M |
| March 31, 2016 | -2.975M |
| December 31, 2015 | -4.19M |
| September 30, 2015 | -1.123M |
| June 30, 2015 | -0.944M |
| March 31, 2015 | -0.441M |
| December 31, 2014 | -0.533M |
| September 30, 2014 | -7.573M |
| June 30, 2014 | -0.78M |
| March 31, 2014 | -0.124M |
| December 31, 2013 | -0.271M |
| September 30, 2013 | -0.12M |
| June 30, 2013 | -0.385M |
| March 31, 2013 | -0.506M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-575.61M
Minimum
Mar 2021
24.08M
Maximum
Mar 2023
-42.07M
Average
-1.635M
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
| Fonar Corp | -0.133M |
| XWELL Inc | 6.822M |
| ProPhase Labs Inc | -1.264M |
| Applied DNA Sciences Inc | 0.00 |
| OncoCyte Corp | 0.241M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 15.55M |
| Cash from Financing (Quarterly) | 0.645M |
| Free Cash Flow | 34.26M |
| Free Cash Flow Per Share (Quarterly) | 0.1786 |
| Free Cash Flow to Equity (Quarterly) | 13.06M |
| Free Cash Flow to Firm (Quarterly) | 13.06M |
| Free Cash Flow Yield | 2.25% |